Gualano, Bruno 
; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana Jessica ; Mazzolani, Bruna Caruso ; Smaira, Fabiana Infante ; Sieczkowska, Sofia Mendes ; Aikawa, Nadia Emi ; Pasoto, Sandra Gofinet ; Medeiros-Ribeiro, Ana Cristina ; Saad, Carla; Yuki, Emily F. N ; Silva, Clovis Artur ; Swinton, Paul Alan ; Hallal, Pedro Curi ; Roschel, Hamilton ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Scandinavian journal of medicine & science in sports. Unidades: FM, EEFE
Subjects: DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, COVID-19, IMUNOSSUPRESSÃO, ATIVIDADE FÍSICA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUALANO, Bruno et al. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine & science in sports, v. 32, n. 10, p. 1510-1515, 2022Tradução . . Disponível em: https://doi.org/10.1111/sms.14213. Acesso em: 08 nov. 2024.APA
Gualano, B., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., Mazzolani, B. C., Smaira, F. I., et al. (2022). Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine & science in sports, 32( 10), 1510-1515. doi:10.1111/sms.14213NLM
Gualano B, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad C, Yuki EFN, Silva CA, Swinton PA, Hallal PC, Roschel H, Bonfa ESD de O. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients [Internet]. Scandinavian journal of medicine & science in sports. 2022 ; 32( 10): 1510-1515.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/sms.14213Vancouver
Gualano B, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad C, Yuki EFN, Silva CA, Swinton PA, Hallal PC, Roschel H, Bonfa ESD de O. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients [Internet]. Scandinavian journal of medicine & science in sports. 2022 ; 32( 10): 1510-1515.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/sms.14213
